Agilon Health (NYSE:AGL) Upgraded by Royal Bank Of Canada to Moderate Buy Rating

Royal Bank Of Canada upgraded shares of Agilon Health (NYSE:AGL) from a hold rating to a moderate buy rating in a report published on Wednesday,Zacks.com reports.

Several other analysts also recently issued reports on AGL. Jefferies Financial Group decreased their price objective on shares of Agilon Health from $2.40 to $1.10 and set a “hold” rating for the company in a report on Friday, August 15th. Zacks Research raised shares of Agilon Health from a “strong sell” rating to a “hold” rating in a research report on Tuesday, October 21st. Benchmark lowered their price target on Agilon Health from $4.00 to $1.50 and set a “buy” rating on the stock in a research report on Wednesday, August 6th. Sanford C. Bernstein reiterated a “market perform” rating and issued a $1.40 price objective (down from $4.00) on shares of Agilon Health in a research note on Wednesday, August 20th. Finally, Wells Fargo & Company cut their price objective on Agilon Health from $1.50 to $1.00 and set an “overweight” rating for the company in a research report on Wednesday, November 5th. Four research analysts have rated the stock with a Buy rating, twelve have given a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Agilon Health has a consensus rating of “Hold” and a consensus target price of $2.73.

Agilon Health Stock Performance

Shares of AGL stock opened at $0.73 on Wednesday. The stock’s 50 day simple moving average is $0.82 and its 200 day simple moving average is $1.44. Agilon Health has a twelve month low of $0.51 and a twelve month high of $6.08. The company has a market capitalization of $300.94 million, a price-to-earnings ratio of -0.97 and a beta of 0.06.

Agilon Health (NYSE:AGL) last announced its earnings results on Tuesday, November 4th. The company reported ($0.27) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.09). Agilon Health had a negative return on equity of 75.92% and a negative net margin of 5.24%.The company had revenue of $1.44 billion for the quarter, compared to the consensus estimate of $1.43 billion. On average, analysts forecast that Agilon Health will post -0.59 EPS for the current fiscal year.

Institutional Investors Weigh In On Agilon Health

Several hedge funds have recently made changes to their positions in the stock. CenterBook Partners LP grew its position in Agilon Health by 492.4% during the third quarter. CenterBook Partners LP now owns 11,428,027 shares of the company’s stock worth $11,771,000 after buying an additional 9,499,012 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Agilon Health by 2.6% in the 2nd quarter. Geode Capital Management LLC now owns 7,156,466 shares of the company’s stock worth $16,462,000 after acquiring an additional 178,477 shares during the period. Bank of America Corp DE lifted its position in shares of Agilon Health by 41.3% in the 3rd quarter. Bank of America Corp DE now owns 5,414,614 shares of the company’s stock worth $5,577,000 after acquiring an additional 1,581,284 shares during the period. Goldman Sachs Group Inc. grew its holdings in shares of Agilon Health by 6.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 5,060,333 shares of the company’s stock worth $21,911,000 after purchasing an additional 311,158 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its position in shares of Agilon Health by 8.8% during the first quarter. Charles Schwab Investment Management Inc. now owns 4,939,576 shares of the company’s stock valued at $21,388,000 after purchasing an additional 398,027 shares during the period.

About Agilon Health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.